Not finding it? Sign in to also search OpenAlex live.
-
An international randomized phase III trial comparing radical hysterectomy and pelvic node dissection (RH) vs simple hysterectomy and pelvic node dissection (SH) in patients with low-risk early-stage cervical cancer (LRESCC): A Gynecologic Cancer Intergroup study led by the Canadian Cancer Trials Group (CCTG CX.5-SHAPE).2023 Journal of Clinical Oncology conference-abstract Medicine Endometrial and Cervical Cancer Treatments Open access
Marie Plante, Janice S. Kwon, Sarah Elizabeth Ferguson, Vanessa Samouëlian, Gwénaël Ferron, Amandine Maulard, +14 more
27citations -
The effectiveness of intratympanic injections with methylPREDnisolon versus placebo in the treatment of vertigo attacks in MENière’s disease (PREDMEN trial): a study protocol for a phase-3 multicentre, double-blinded, randomised, placebo-controlled trial
Maud Boreel, Babette F. van Esch, Tjard R. Schermer, Berber M. Mol, Peter Paul G. van Benthem, Tjasse Doewe Bruintjes
2citations -
Sleep disturbances in the prodromal phase of mood episodes in patients with bipolar disorder: a replicated single-case design2025 Journal for Person-Oriented Research article Medicine Bipolar Disorder and Treatment Open access
Stefan E. Knapen, Evelien Snippe, Arnout Christiaan Smit, Robert A. Schoevers, Rixt F. Riemersma‐van der Lek
1citations -
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study2020 The Lancet Haematology article Medicine Multiple Myeloma Research and Treatments Open access cited by 2 patents
Michèle Cavo, Francesca Gay, Meral Beksaç, Lucia Pantani, Maria Teresa Petrucci, Meletios Athanasios Dimopoulos, +54 more
384citations -
Subcutaneous Daratumumab (DARA) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Overall Survival and Final Major Organ Deterioration Progression-Free Survival Results from the Phase 3 Andromeda Study2024 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Efstathios Kastritis, Giovanni O. Palladini, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, Hans Chulhee Lee, +24 more
15citations -
Lower-dosing ponatinib in pre-treated GIST: Results of the POETIG phase II trial.2020 Journal of Clinical Oncology conference-abstract Medicine Gastrointestinal Tumor Research and Treatment
Johanna Falkenhorst, Rainer Hamacher, Peter Reichardt, Philipp Ivanyi, Bernd Kasper, Peter Hohenberger, +6 more
6citations -
International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100
Louis Fox, Marieke van Leeuwen, Jennifer M. Jones, Amal Al‐Omari, Haneen Abaza, Muna Alkhaifi, +57 more
2citations -
Detection of highly hydrophilic glycopeptides in reverse-phase liquid chromatography-mass spectrometry after TMTPro Zero labeling2026 Carbohydrate Polymers article Biochemistry, Genetics and Molecular Biology Glycosylation and Glycoproteins Research Open access
Dario A. T. Cramer, Anabel Torrente-López, Alan B. Moran, Carolien A. M. Koeleman, Ali Al Kaabi, Chakkumkal Anish, +2 more
0citations -
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006)2022 Journal of Clinical Oncology article Medicine Ovarian cancer diagnosis and treatment Open access cited by 2 patents
Janos Laszlo Tanyi, Leslie M. Randall, Setsuko K. Chambers, Kristina A. Butler, Ira Seth Winer, Carrie L. Langstraat, +8 more
178citations -
Addition of Isatuximab to Lenalidomide, Bortezomib and Dexamethasone As Induction Therapy for Newly-Diagnosed, Transplant-Eligible Multiple Myeloma Patients: The Phase III GMMG-HD7 Trial
Hartmut Goldschmidt, Eva Nievergall, Roland R. Fenk, Uta Bertsch, Diana Tichy, Britta Besemer, +25 more
33citations -
Phase 3, randomized, single-dose, open-label study to investigate the safety and efficacy of pafolacianine sodium injection (OTL38) for intraoperative imaging of folate receptor positive ovarian cancer.2021 Journal of Clinical Oncology conference-abstract Medicine Ovarian cancer diagnosis and treatment
Janos Laszlo Tanyi, Hye Sook Chon, Mark Aloysuis Morgan, Setsuko K. Chambers, Ernest Soyoung Han, Kristina A. Butler, +6 more
23citations -
OP0004 ABATACEPT IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS: RESULTS FROM THE ARTHRITIS PREVENTION IN THE PRE-CLINICAL PHASE OF RA WITH ABATACEPT LONG TERM OUTCOMES (ALTO) STUDY2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Andrew Paul Cope, Marianna Jasenecova, Joana Carvalho Vasconcelos, Andrew D. Filer, K. Raza, Maria Antonietta D’Agostino, +16 more
5citations -
Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study2024 Inflammatory Bowel Diseases article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access cited by 2 patents
Hiroshi Nakase, Silvio Danese, Walter Reinisch, Timothy E. Ritter, Yan Liang, Emily Wendt, +10 more
5citations -
Efficacy, Safety, and Quality of Life of Pegcetacoplan in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria Treated within the Phase 3 PEGASUS Trial2024 Acta Haematologica article Immunology and Microbiology Complement system in diseases Open access
Hisakazu Nishimori, Hideyuki Nakazawa, Shinobu Tamura, Toshiki Uchida, Kensuke Usuki, Johan Szamosi, +3 more
4citations -
A Phase 3, Randomized, Double-Blind, Active-Comparator-Controlled Study of Bomedemstat Versus Hydroxyurea in Patients with Essential Thrombocythemia Naïve to Cytoreductive Therapy2024 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Yuka Sugimoto, Eran Zimran, Yoshimitsu Shimomura, Hiroki Yamaguchi, Hans Carl Hasselbach, Jean‐Jacques Kiladjian, +14 more
2citations -
Sustained Improvement in Health-Related Quality of Life in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone: Update of the Phase 3 MAIA Trial
Aurore Perrot, Thierry T.F. Facon, Shaji Kunnathu Kumar, Torben Plesner, Robert Zygmunt Orlowski, Philippe Moreau, +24 more
1citations